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Abstract 
Background: Heads of Government from Asia and the Pacific have committed to a malaria-free region by 2030. In 2015, 
the total number of confirmed cases reported to the World Health Organization by 22 Asia Pacific countries was 2,461,025. 
However, this was likely a gross underestimate due in part to incidence data not being available from the wide variety of 
known sources. There is a recognized need for an accurate picture of malaria over time and space to support the goal of 
elimination. A survey was conducted to gain a deeper understanding of the collection of malaria incidence data for sur-
veillance by National Malaria Control Programmes in 22 countries identified by the Asia Pacific Leaders Malaria Alliance.
Methods: In 2015–2016, a short questionnaire on malaria surveillance was distributed to 22 country National Malaria 
Control Programmes (NMCP) in the Asia Pacific. It collected country-specific information about the extent of inclusion 
of the range of possible sources of malaria incidence data and the role of the private sector in malaria treatment. The 
findings were used to produce recommendations for the regional heads of government on improving malaria surveil-
lance to inform regional efforts towards malaria elimination.
Results: A survey response was received from all 22 target countries. Most of the malaria incidence data collected by 
NMCPs originated from government health facilities, while many did not collect comprehensive data from mobile and 
migrant populations, the private sector or the military. All data from village health workers were included by 10/20 
countries and some by 5/20. Other sources of data included by some countries were plantations, police and other 
security forces, sentinel surveillance sites, research or academic institutions, private laboratories and other govern-
ment ministries. Malaria was treated in private health facilities in 19/21 countries, while anti-malarials were available in 
private pharmacies in 16/21 and private shops in 6/21. Most countries use primarily paper-based reporting.
Conclusions: Most collected malaria incidence data in the Asia Pacific is from government health facilities while data 
from a wide variety of other known sources are often not included in national surveillance databases. In particular, 
there needs to be a concerted regional effort to support inclusion of data on mobile and migrant populations and the 
private sector. There should also be an emphasis on electronic reporting and data harmonization across organizations. 
This will provide a more accurate and up to date picture of the true burden and distribution of malaria and will be of 
great assistance in helping realize the goal of malaria elimination in the Asia Pacific by 2030.
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Background
Malaria remains a major cause of death and illness with 
an estimated 2.1 billion people in the Asia Pacific at risk 
of infection [1]. With the growing threat of anti-malarial 
drug resistance and the urgent need to contain its spread 
in the Greater Mekong Subregion (GMS) [2–5], malaria 
is a major regional public health concern. Not recogniz-
ing national borders, control and elimination will require 
coordination between countries and across sectors to 
minimize the further loss of lives and valuable resources.
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At the 2013 East Asia Summit (EAS), the Asia Pacific 
Leaders Malaria Alliance (APLMA) was established to 
accelerate progress towards a reduction in malaria cases 
and deaths. In 2014 at the ninth EAS, the APLMA Co-
Chairs (the Prime Ministers of Viet Nam and Australia) 
tabled a recommendation for the Asia Pacific region to 
become free of malaria by 2030. The EAS Heads of Gov-
ernment agreed to the goal, and tasked APLMA Co-
Chairs to present a plan to reach malaria elimination 
through a “Leaders Malaria Elimination Roadmap” [6]. 
This roadmap was presented to Heads of Government 
during the 10th EAS Meeting in 2015 [7]. With support 
from the Australian government, APLMA worked with 
the Mahidol Oxford Tropical Medicine Research Unit 
(MORU) to build an evidence base that will be used to 
inform decisions on malaria elimination. MORU devel-
oped a report on the status of malaria elimination in the 
Asia Pacific and collected data on malaria surveillance 
from each National Malaria Control Programme 
(NMCP) in the Asia Pacific.
For malaria elimination to succeed, it is essential to 
have an accurate picture of malaria incidence over time 
and space. In 2015, the total number of confirmed cases 
reported to the World Health Organization (WHO) 
by 22 Asia Pacific countries identified by APLMA was 
2,461,025 (Fig. 1) [8]. However, in many countries, availa-
ble information on malaria incidence is incomplete. Most 
NMCPs routinely collect malaria incidence data for sur-
veillance predominantly from government health facili-
ties and this is the main dataset that is reported to WHO. 
The completeness of these data and extent to which 
data from hospitals and community health workers are 
included is thought to vary greatly. In many countries, a 
range of other organizations including non-governmental 
organizations (NGOs), the private sector and the mili-
tary have a major role in providing malaria care but do 
Fig. 1 Confirmed malaria cases in 22 Asia Pacific countries in 2015 [8]
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not contribute data to the NMCP malaria surveillance 
system. Even where some of this information is available, 
it often does not reach the NMCP quickly enough for 
timely response planning. This incomplete reporting of 
malaria incidence can result in a very inaccurate picture 
of the distribution of malaria and a gross underestimate 
of the disease burden for the NMCP. However, the extent 
to which malaria incidence data are collected from these 
various sources by each country is not well described.
Incomplete reporting of malaria incidence greatly 
impedes allocation of appropriate resources within gov-
ernments and impairs efficient targeting of malaria con-
trol interventions. It also constrains access to external 
funding where disease burdens are underestimated. A 
complete and accurate picture of malaria incidence is 
essential to show reliable evidence that a country is mov-
ing towards elimination [9, 10]. Additionally, harmonized 
sharing of reliable and complete data between countries 
would facilitate direct comparability of datasets across 
international borders. Ongoing efforts to increase this 
harmonization will help underpin regional conversations 
about malaria elimination and will greatly improve coor-
dination between NMCPs.
This study assessed the current sources of malaria sur-
veillance data collected by NMCPs and the role of the 
private sector in malaria treatment in the Asia Pacific 
region. At the time of this survey, target countries had 
either ongoing local malaria transmission or were work-
ing towards certification for malaria elimination [11, 12].
Methods
A short self-administered questionnaire was developed to 
collect information from each country about the system 
for collection of malaria incidence data and treatment in 
the private sector. The survey was developed in consulta-
tion with staff from selected NMCPs and regional policy-
makers. Following iteration incorporating their feedback, 
it was designed to be as short and clear as possible to max-
imize the likelihood of receiving responses while maintain-
ing clarity of the information collected. The final questions 
were in three sections. Section (a) what sources of malaria 
incidence data are collected by the NMCP in (country) … ? 
A row was provided for each category listed in Fig. 2 with 
choices of “all”, “some” or “none” for the extent to which 
data from each source was included in the national surveil-
lance database plus a space to add free text comments or 
clarifications for each category. Space was also provided 
for countries to add any additional sources not already 
listed. Section (b) details were requested of the system 
for collecting and collating incidence data in that country. 
Section (c) a set of questions to determine the role of the 
private sector in malaria treatment, as shown in Fig. 3. 
In 2015 to 2016, the survey was conducted with the 
assistance of APLMA among 22 target countries in the 
Asia Pacific: Afghanistan, Bangladesh, Bhutan, Cam-
bodia, People’s Republic of China (hereafter referred to 
as China), Democratic People’s Republic of Korea (DPR 
Korea), India, Indonesia, Republic of Korea, Lao People’s 
Democratic Republic (Lao PDR), Malaysia, Myanmar, 
Nepal, Pakistan, Papua New Guinea, Philippines, Solo-
mon Islands, Sri Lanka, Thailand, Timor-Leste, Vanuatu 
and Viet Nam. The data collection tool was either admin-
istered in person or sent through email to key persons 
in the NMCP of each country. Follow-up was done by 
telephone and email to clarify unclear or incomplete 
responses. Survey data were encoded and stored in a 
secured database (Microsoft Access 2013). Summary fig-
ures were produced to facilitate effective communication 
of findings to policymakers and the APLMA member 
country Heads of Government.
Results
Description of survey participants
All 22 country NMCPs completed the survey by May 
2016. Of these, 14 respondents (64%) identified them-
selves as the NMCP director or manager, five (23%) were 
staff members from the NMCP and three (14%) others 
worked in close collaboration with the NMCP. Survey 
results on the different sources of malaria surveillance 
data as collected by NMCPs are shown in Fig. 2.
Sources of malaria surveillance data according to NMCPs
Government sources
Twenty-two countries reported that they collect malaria 
incidence data from government health facilities. Seven-
teen collected all information from health centres/clinics 
while five only collected some. In hospitals, 18 collected 
all information while four only collected some. In 21 
countries that diagnose malaria in the military (not the 
Solomon Islands), only 10 collected all data while eight 
others collecting some data. The police and other secu-
rity forces were also identified as sources of malaria inci-
dence data in Cambodia, Nepal and Viet Nam.
Village health workers, mobile health workers, mobile 
and migrant populations
Out of 20 countries with village health workers (not DPR 
Korea and Solomon Islands), all malaria incidence data 
were included by 10 whereas five only collected some 
data. In the 19 countries with mobile heath workers (not 
DPR Korea, Papua New Guinea and Sri Lanka), five col-
lected all data while six only collected some data. Only 
four NMCPs collected all data and 10 only collected 
some from mobile and migrant populations.
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Non‑governmental organizations
NGOs were reported to provide some malaria care in 
21 countries, except for the Republic of Korea. Of those 
countries, six collected all incidence data from NGOs 
while 10 collected some data.
Private sector
Information collected on the role of the private sector in 
malaria care is summarized in Fig.  3. The private sector 
for health was reported to exist in all countries except in 
DPR Korea. Information on private sector malaria treat-
ment or availability of anti-malarials were not available for 
Vanuatu. It was reported that malaria was being treated 
in the private sector in 19 of 20 (95%) countries (with the 
exceptions of Bhutan and Sri Lanka). All these 19 coun-
tries reported that malaria treatment occurred in private 
health facilities (clinics or hospitals). All data from private 
clinics were collected in five countries while some data 
were included in 10. Three countries reported that they 
do not have private hospitals (Bhutan, DPR Korea and 
Solomon Islands). Of those countries with private hospi-
tals, 16 reported that they treat malaria, while two were 
uncertain. Three countries collected all, and 10 collected 
some malaria incidence data from private hospitals.
Anti-malarials were reported as being available in pri-
vate pharmacies in 16 countries and private shops in six 
of these same countries. Of these, shops or pharmacies 
















































































































































All data Some data  Does not exist
Fig. 2 Questionnaire responses on sources of malaria incidence data collected by each NMCP. Additional sources of data were identified in nine 
countries and were labeled as follows: a tea estates; b police; c sentinel surveillance sites; d railways, Central Government Health Scheme, Employ-
ees’ State Insurance and Public Sector Undertakings; e police provincial hospitals, provincial anti-malaria stations; f Institute of Medical Research 
sites; g private laboratories, university parasitology departments; h Border guards, Ministries of Agriculture and Rural Development, Transportation, 
Industry and Trade. ‘All data’/‘Some data’/‘No data’ = the extent to which data from that source are collected by the NMCP. ‘Does not exist’ indicates 
that the source does not exist in that country
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(31%) countries. Only four countries in the region stated 
that anti-malarials were not available in private shops or 
pharmacies (Bhutan, China, Sri Lanka and Thailand).
Other sources
Other sources of malaria incidence data were cited by 
some countries in the Asia Pacific, with varying extents 
of data collection. These included data from plantations, 
sentinel surveillance sites, research or academic institu-
tions, private laboratories and government agencies out-
side the Ministry of Health.
Situation in the Greater Mekong Subregion
Five of six countries in the GMS (except Thailand) col-
lected all information on malaria incidence from gov-
ernment health facilities. In addition, village health 
workers, mobile and migrant populations and the mili-
tary also contributed to the national surveillance data-
sets of all GMS member countries. All countries in the 
GMS reported treatment of malaria in the private sector. 
No information on malaria incidence was collected by 
NMCPs from the private sector in Myanmar, Thailand or 
Viet Nam.
System for collecting and collating malaria incidence data 
in the Asia Pacific
Fourteen of 17 (82%) countries reported that they use 
paper-based collection of incidence data at the level of 
individual health facilities and/or healthcare providers. 
These data were then aggregated and entered into an 
electronic database. The administrative level at which 
this electronic data entry occurred varied widely between 
countries. Seven of these 15 (47%) countries reported 
that they have in addition, or were in the process of roll-
ing out, an electronic reporting system (short text mes-
saging, smartphone or web-based) at facility level. Three 
of 17 (18%) countries reported already using primarily 
electronic reporting. Four countries did not specify about 
paper-based versus electronic data collection and one 
country provided no reply for this section of the survey.
Discussion
This survey demonstrates the wide range of poten-
tial sources of malaria surveillance data across the Asia 
Pacific region. Being across a wide range of organiza-
tions, it can be very challenging for an NMCP to collect 
data from all of these sources. In all countries, the main 
source of malaria incidence data as collected by NMCPs 
was from government health facilities from which data 
were complete in two-thirds of countries in this study. 
Half of the countries collected complete information 
from village health workers, whose contribution has 
been considered crucial in achieving malaria elimina-
tion [13–15], although they were present in all but two. 
Collection of data from mobile and migrant popula-
tions, NGOs, the private sector and the military—all 
potentially important sources of malaria data in many of 
these countries—was much less comprehensive. Much 
malaria treatment occurred in the private sector (clin-
ics, hospitals, pharmacies and shops) in most countries 
but few collected data from these sources. Engaging the 
private sector is one of the major challenges for malaria 
elimination in many countries [16, 17], although there 
have been some notable successes [18]. This survey also 
documented the existence of additional but potentially 
important sources of malaria surveillance data in nine 
countries including other government ministries and the 
police. Overall, these findings suggest malaria incidence 
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No No response
 Not sure
Fig. 3 Questionnaire responses about private sector treatment 
of malaria in each country. The questions asked are shown at the 
top. ‘Not sure’ the respondent did not know the answer, ‘Does not 
exist’ that entity does not exist in that country, ‘No response’ no 
response was provided to that question
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information from a wide range of potential sources. This 
study did not attempt to quantify the possible magni-
tude of the incidence information that could be collected 
from these sources, although it has been suggested that 
in some countries, for example Pakistan, the majority of 
cases may be missed [16]. Attempts have been made to 
try to estimate the overall number of malaria cases in 
each country, most notably by the WHO for the annual 
World Malaria Report [8]. However, such estimates have 
a wide range of uncertainty due to the limitations of the 
available data. This lack of a complete picture of malaria 
burden could hinder current progress made towards 
national and regional malaria elimination goals [3, 6, 19]. 
The WHO characterized a malaria surveillance system as 
being effective if it could enable programme managers to 
identify the areas or population groups mostly affected by 
malaria, identify trends in cases and deaths that require 
additional interventions and assess the impact of control 
measures [9]. The success of planning for control and 
elimination relies heavily on having an accurate picture of 
malaria incidence, mainly through surveillance [20].
In the light of these findings, the authors propose two 
general recommendations. First, a regional effort is war-
ranted to include additional sources of malaria case data 
in the national surveillance database for each country, 
in particular from village health workers, mobile and 
migrant populations, the private sector, NGOs and the 
military. This should include facilitating links for the 
NMCPs to engage with a much wider community of data 
collectors. Second, there should be continued support in 
countries to improve the completeness of malaria sur-
veillance data collected from existing sources. Courses 
of action would necessitate steady leadership, informa-
tion infrastructure and funding support, both within and 
between countries in the region [21–23]. In addition, 
there is a need to build an international network of col-
laborators on assembly of malaria data from the various 
sources and to facilitate sharing of solutions and best 
practices to help move the malaria information base 
closer to comprehensive coverage.
Most countries collected incidence data at facility level 
using paper forms and aggregated data for entry into an 
electronic database at different administrative levels that 
varied widely between countries. Many countries also 
had, or were in the process of rolling out, electronic data 
collection systems (short text messaging, smartphone 
or web-based). Although often expensive to implement, 
electronic data collection systems have the advantage that 
data can be collected into a central Health Information 
System more rapidly thus potentially providing a more 
up to date picture for the NMCP and increasing the effi-
ciency of elimination efforts [24, 25]. A third recommen-
dation from this study is that wherever possible, collection 
of incidence data from all sources should be done elec-
tronically at the level of the individual facility or health-
care provider into a centralized system accessed by the 
NMCP. Collation of data from multiple sources within a 
country is another major potential bottleneck with differ-
ent organizations using their own reporting formats and 
standalone database systems. Electronic data collection 
and collation should thus ideally include harmonization of 
data reporting formats and use of a single electronic data 
collection tool across multiple organizations.
For malaria elimination to succeed, it is impor-
tant to have an up to date regional picture of malaria 
burden. This is particularly important in areas with 
cross-border movement of people with malaria where 
elimination efforts should be coordinated between coun-
tries and detailed information from either side of borders 
is needed. In Fig. 1, the authors created a map showing a 
summary of confirmed malaria cases by country. This 
was produced using publicly available data. Producing 
maps using subnational level data from multiple coun-
tries is currently far more challenging with inaccurate or 
unavailable geographic information, out of date popula-
tion estimates and no common platform for sharing and 
harmonization of disease data between countries at sub-
national level. Various efforts are underway to remedy 
this.
This study had some limitations. In order to achieve a 
high response rate from multiple busy NMCPs, the sur-
vey was necessarily brief and simplistic. It was in no way a 
comprehensive assessment of surveillance systems, focus-
ing instead on three priority areas. The survey responses 
were selected from pre-specified options that were quali-
tative in nature. To elicit more context, respondents were 
given the chance to write their remarks after each close-
ended item, although not all of them did so. Country 
NMCPs were also asked to describe the system for how 
they collect and collate malaria incidence data, including 
the role of the private sector in treatment. Moreover, the 
profile of respondents varied in terms of experience and 
function in the NMCP. In an attempt to gain insights from 
the most qualified person, survey forms were initially sent 
out to NMCP directors or managers in each country. In 
countries where this was not possible, this was delegated 
and other qualified staff or collaborators were able to 
provide responses. The responses were necessarily cat-
egorical due to a lack of quantitative information on the 
relative contribution of the various sources. It is possible 
that there are other potential sources of malaria incidence 
data that were not identified by the survey respondents. 
In addition, it is likely that within individual categories 
there will be sources about which the NMCP is unaware, 
for example specific private sector providers like mining 
companies [26] and plantations [27].
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Efforts to improve surveillance are ongoing and some 
of the responses here may no longer apply. Despite the 
limitations, the study found some important patterns 
in the way malaria incidence data are collected in mul-
tiple countries. This facilitates the identification of gaps 
in malaria surveillance and promotes regional planning 
of strategies for malaria elimination and control.
Conclusions
Most collected malaria incidence data in the Asia Pacific is 
from government health facilities while data from a wide 
variety of other known sources are not included. In par-
ticular, there needs to be a concerted regional effort to sup-
port inclusion of data on mobile and migrant populations 
and the private sector. There should also be an emphasis 
on electronic reporting and data harmonization across 
organizations. This will provide a much more accurate and 
up to date picture of the true burden and distribution of 
malaria and will be of great assistance in helping realize 
the goal of malaria elimination in the Asia Pacific by 2030.
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